Commercial Cell Therapy Experience Using Mycoplasma NAT For Product Release: Five-Year Review
Posted on October 14, 2022
Adam Barron, Director, Research & Development
Mark Troddyn, Quality Control Professional
Julia Wallace, Scientist, Research & Development
John Duguid, Executive Director, Research & Development
Vericel Corporation
Introduction Autologous cell therapy products are patient-specific therapies that use cells harvested from a single patient to treat that same patient. Living cell constructs cannot be terminally sterilized and typically have a shelf life measured in days rather than months. Final product release te...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy